Pharmaceutical - Journal of Pharmaceutics & Pharmacology https://www.avensonline.org/ Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19 https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0031.html 10 September 2020 Smieszek SP, Przychodzen BP, and Polymeropoulos MH The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0032.html 21 September 2020 Aranda-Abreu GE, Hernández-Aguilar ME, Herrera-Covarrubias D and Rojas-Durán F Amantadine for the Treatment of SARS-Cov-2: Case Report https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0033.html 21 September 2020 Aranda-Abreu GE, Aranda-Martínez JD and Araújo R Adamantanes for the Prevention of COVID-19: A Review of Case Reports https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0034.html 29 September 2020 Cortes Borra A Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0035.html 16 September 2020 Butterworth Roger F Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19 https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0037.html 12 October 2020 Butterworth Roger F Repurposing of Adamantanes with Transmitter Receptor Antagonist Properties for the Prevention/Treatment of COVID-19 https://www.avensonline.org/fulltextarticles/JPP-2327-204X-08-0038.html 24 November 2020 Brenner SR and Butterworth RF Potential for the Repurposing of Adamantanes for the Treatment of Covid-19 24 November 2020 Roger F Butterworth Aticaprant (Clinically Developed Kappa-Opioid Receptor Antagonist) Combined With Naltrexone Prevents Alcohol “Relapse” Drinking https://www.avensonline.org/fulltextarticles/JPP-2327-204X-09-0032.html 16 May 2022 Zhou Y, Zhou DC and Kreek MJ Inhibitory Effect of 5,7-Dimethoxyfl avone On Rosuvastatin Uptake From The Apical Membrane Of Caco-2 Cells https://www.avensonline.org/fulltextarticles/JPP-2327-204X-09-0033.html 15 November 2022 Kimura O, Ohta C2, Koga N, Kato Y, Haraguchi K and Endo T